Condition: Mycosis Fungoides · Non-Hodgkin's Lymphoma · Sponsor: Stanford University
The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.
This description comes directly from the study's public registry record.
Tatiana Neal · 650-709-7838 · tatianan@stanford.edu
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Recruiting |
| Stanford University, School of Medicine | Palo Alto, California, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| University of Pittsburg | Pittsburgh, Pennsylvania, United States | Recruiting |
| University of Texas Southwestern | Dallas, Texas, United States | Recruiting |
| University of Utah Hospital | Salt Lake City, Utah, United States | Recruiting |
| Hospital Italiano de Buenos Aires | Buenos Aires, Argentina | Recruiting |
| Peter MacCallum Cancer Center, | Melbourne, Australia | Recruiting |
| University of Sao Paulo Medical School | São Paulo, Brazil | Recruiting |
| Peking University First Hospital | Beijing, China | Recruiting |
| The University of Tokyo | Tokyo, Japan | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02848274